DANSK BIOTEK & Unilabs A/S invite you to a workshop on Epitope mapping, CAR-T cell therapy and gene therapy
The Biotech & MedTech industry are increasingly complex from a commercial, regulatory, and clinical perspective. Join us to learn about essential development steps to take and get inspiration about how to integrate these requirements into your lifecycle planning for increased success and sustainable growth.
Agenda:______________ |
|
13:30 | Registration and networking |
13:50 | Welcome by DANSK BIOTEK and Peder S. Andersen, Head of Business Development at Unilabs A/S |
14:00 | Thomas Mørch Frøsig PhD, CEO and Founder at ImmuMap Services
Introduction to Immuno-oncology Introduction to T cell epitope mapping and its use for biological evaluation and immunotoxicology Current approach for utilizing neoepitopes as targets in clinical treatments and a proposed strategy for increasing clinical efficacy |
14:30 | Houman Pourhassan PhD, COO at ImmuMap Services
Case study, investigating alloreactivity of genetically modified T cells for cancer-treatment |
14:45 | Ôzcan Met PhD, Head Cell Production Unit, Center for Cancer Immune Therapy, Herlev University Hospital
Adoptive T-cell Immunotherapy for Cancer |
15:30 | Annkatrin Herrmann, Scientist at Unilabs A/S
Case Study: Assay Development & Validation for Immunogenicity Testing in Gene Therapy programs |
16:00 | Networking and refreshments |
The event is free of charge for members; non-members will be charged a fee of 500 DKK